Evidence map›Paper›PMID 25875015›Full record

ArticlePloS one2015

Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPβ.

Makoto Shimizu, Juan Li, Jun Inoue, Ryuichiro Sato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Flavonoids, gut microbiota, and host lipid metabolism.Engineering in life sciences · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Makoto ShimizuDepartment of Applied Biological Chemistry, The University of Tokyo 1-1-1 Yayoi, Bunkyo, Tokyo, Japan.
Juan LiDepartment of Applied Biological Chemistry, The University of Tokyo 1-1-1 Yayoi, Bunkyo, Tokyo, Japan.
Jun InoueDepartment of Applied Biological Chemistry, The University of Tokyo 1-1-1 Yayoi, Bunkyo, Tokyo, Japan.
Ryuichiro SatoDepartment of Applied Biological Chemistry, The University of Tokyo 1-1-1 Yayoi, Bunkyo, Tokyo, Japan.
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quercetin is one of the most abundant polyphenolic flavonoids found in fruits and vegetables and has anti-oxidative and anti-obesity effects. Because the small intestine is a major absorptive organ of dietary nutrients, it is likely that highly concentrated food constituents, including polyphenols, are present in the small intestinal epithelial cells, suggesting that food factors may have a profound effect in this tissue. To identify novel targets of quercetin in the intestinal enterocytes, mRNA profiling using human intestinal epithelial Caco-2 cells was performed. We found that mRNA levels of some apolipoproteins, particularly apolipoprotein B (apoB), are downregulated in the presence of quercetin. On the exposure of Caco-2 cells to quercetin, both mRNA and protein levels of apoB were decreased. Promoter analysis of the human apoB revealed that quercetin response element is localized at the 5'-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. We found that quercetin reduces the promoter activity of apoB, driven by the enforced expression of C/EBPβ. Quercetin had no effect on either mRNA or protein levels of C/EBPβ. In contrast, we found that quercetin inhibits the transcriptional activity of C/EBPβ but not its recruitment to the apoB promoter. On the exposure of Caco-2 cells to quercetin 3-O-glucuronide, which is in a cell-impermeable form, no notable change in apoB mRNA was observed, suggesting an intracellular action of quercetin. In vitro interaction experiments using quercetin-conjugated beads revealed that quercetin binds to C/EBPβ. Our results describe a novel regulatory mechanism of transcription of apolipoprotein genes by quercetin in the intestinal enterocytes.

Indexed as

Apolipoproteins BCaco-2 CellsCCAAT-Enhancer-Binding Protein-betaGene Expression RegulationHumansPromoter Regions, GeneticQuercetinRNA, MessengerTranscriptional ActivationApolipoproteins BCCAAT-Enhancer-Binding Protein-betaQuercetinRNA, Messenger

Identifiers

PMID25875015
PMCPMC4398426
OpenAlexW2158614723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.